Metropolia University of applied sciences
Helsinki, Finland
NCT Number: NCT05278416
The study is a single site, randomized clinical trial designed to determine the efficacy of the Lumoral treatment in periodontitis patients.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Helsinki, Finland
Lumoral treatment is a CE-marked medical device developed to provide a potent, targeted antibacterial action on dental plaque in a home environment. The device mechanism of action is antibacterial photodynamic therapy. The device is used by swishing a mouth rinse, strongly adhering to dental plaque. The plaque-adhered photoactive mouth rinse can be activated by a simple use light applicator. The antibacterial efficacy far exceeds chlorhexidine, without side effects in long-term use. Preliminary results have shown a promising anti-inflammatory response in addition to plaque reduction.
This early-stage study is designed to determine the efficacy of the Lumoral method in periodontitis patients. Improved supragingival plaque control can help to also sustain subgingival plaque management in the long term. In addition, the device might have a photobiomodulation effect on periodontal tissues.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will use Lumoral treatment -device and Lumorinse tablets daily as per protocol.
Time frame: 6 months
Clinical change concerning bleeding on probing change. A full-mouth assessment at six sites per tooth (mesiobuccal, buccal, distobuccal, mesiolingual, lingual, distolingual). Gingival bleeding is considered as positive if bleeding occurs within 15 seconds after gentle probing with a probe at the sulcus. Dichotomous scoring to each site of the tooth as bleeding "1 present" and "0 absent". BOP is reported as the percentage (%) of sites with positive findings. Calculation formula: number of bleeding sites/ 6 times number of teeth.
Time frame: 6 months
Observation of clinical attachment level:
A full-mouth assessment, measured at six sites per tooth. Assessed as the distance from the cementoenamel junction (CEJ) to the bottom of the periodontal pocket (mm). To calculate CAL, two measurements are needed:
distance from the gingival margin to the CEJ and PPD; in recession: PPD + gingival margin to the CEJ; in tissue overgrowth: PPD - gingival margin to the CEJ.
Time frame: 6 months
A full-mouth assessment, measured at six sites per tooth. Assessed from the base of the pocket to the gingival margin (mm)
Time frame: 6 months
Absence of device-related serious adverse events or any patterns of device-related adverse events graded as moderate
Time frame: 6 months
Change in aMMP8-measurement reflecting the reduction in periodontitis grade. The oral rinse fluid sample collection and the aMMP-8 marker analysis will be performed using Periosafe test (Dentognostics GmbH) according to the manufacturer's instructions.
Time frame: 6 months
Assessment of six index teeth, measured at four sites per tooth
Dichotomous scoring to each site of the tooth as plaque "1 present" and "0 absent" VPI reported as the percentage (%) of sites with plaque Calculation formula: number of sites with plaque/ 4 times number of teeth.
Time frame: 6 months
Patient related objectives: Oral-related quality of life measurement (OHIP-14) questionnaire.
Time frame: 6 months
Measurements of internal motivation to dental hygiene by Perceived Competence Scale (PCS) questionnaire.
Time frame: 6 months
Measurements of internal motivation to dental hygiene by Oral Self-Care Assessment (OSCA) questionnaire
Koite Health Oy
Industry
Regular Home Use of Dual-light Photodynamic Therapy in the Management of Chronic Periodontitis.
Acronym: HOPE-CP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06341439
Mouth Diseases, Pathological Conditions, Anatomical
L’Aquila, Italy
View Trial DetailsNCT05425784
Dental Deposits, Dental Plaque
Kemi, Lapland, Finland
View Trial DetailsNCT05361590
Dental Deposits, Dental Plaque
Tampere, Pirkanmaa, Finland
View Trial DetailsNCT02718014
Inflammation, Menopause
View Trial Details